Learn More
Selleck Chemical LLC Elotuzumab-A2034-1MG

Supplier: Selleck Chemical LLC A20341MG
Elotuzumab (anti-SLAMF7 BMS-901608 PDL063 HuLuc63) is a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7 also known as CS1 CD319 or CRACC) Elotuzumab shows a dual mechanism of action that includes the direct activation of natural killer (NK) cells and the induction of NK cell mediated antibody-dependent cellular cytotoxicity
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.